Abstract
The capacity of benorylate, an ester of acetylsalicylic acid and paracetamol, to reduce fever in children was compared with that of the components as such or as a combination. The series of cases studied consisted of 66 patients between the ages of 4 months and 12 years with rectal temperatures above 38.5°C. Temperatures were recorded at 15 and 20 min and 1, 2, 4 and 6 hrs after the administration of the drug.
The antipyretic effect of combined acetylsalicylic acid (11 mg/kg) and paracetamol (14 mg/kg) was superior to the effect of benorylate with a dose of 25 mg/kg and even of 50 mg/kg as well as better than the effect of either drug alone.
Acetylsalicylic acid (10 mg/kg) and paracetamol (12.5 mg/kg) alone produced a significantly greater antipyretic effect than benorylate with a dose of 25 mg/kg.
Given in a dose of 35–40 mg/kg, benorylate seems to have a significant antipyretic effect. However, this effect is clearly smaller than that of either of its components, acetylsalicylic acid or paracetamol. Therefore benorylate is probably not suitable to be used as a general antipyretic agent in children.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
References
Alexander, F., Flahaut, J., Raveschot, H., Drykoningen, G.: A study of the antipyretic activity of a new substance, benorylate in pediatrics. Brux.-méd. 50, 439 (1970)
Beales, D. L., Burry, H. C., Graham, R.: Comparison of aspirin and benorylate in the treatment of rheumatoid disease. Brit. med. J. 1972 II, 483
Colgan, M. T., Mintz, A. A.: The comparative effect of N-acetyl-p-aminophenol and acetylsalicylic acid. J. Pediat. 50, 552 (1957)
Eden, A. N., Kaufman, A.: Clinical comparison of three antipyretic agents. Amer. J. Dis. Child. 114, 284 (1967)
Hunter, J.: Study of antipyretic therapy in current use. Arch. Dis. Childh. 48, 313 (1973)
Kolle, G. von: Zur Behandlung der juvenilen chronischen Polyarthritis und des Still-Syndroms mit einem neuen Antirheumaticum. Z. Rheumaforsch. 30, 227 (1971)
Kouvalainen, K.: Lasten kuumeen hoito. Duodecim (Helsinki) 90, 101 (1974)
Millichap, J. G., Aledort, L. M., Madsen, J. A.: A critical evaluation of therapy of febrile seizures. J. Pediat. 56, 364 (1960)
Powell, R. H., Ansell, B. M.: Benorylate in management of Still's disease. Brit. med. J. 1974 I, 145
Robertson, A.: Benorylate absorption and metabolism. Abstracts of papers in 8th Europ. Rheum. Conference (1971)
Robertson, A., Glynn, J. P., Watson, A. K.: The absorption and metabolism in man of 4-(acetamido)phenyl-2-acetoxybenzoate (Benorylate). Xenobiotica 2, 339 (1972)
Rosner, I., Malhie, P., Mottot, G.: Pharmacologie du 4-(acétamido) phenyl-2-acétoxybenzoate (Win 11450). Thérapie 23, 525 (1968)
Steele, R. W., Young, F. S. H., Bass, J. W., Shirkey, H. C.: Oral antipyretic therapy. Evaluation of aspirin-acetaminophen combination. Amer. J. Dis. Child. 123, 204 (1972)
Weill, J., Gaillon, R., Renon, C., Lejeune, C.: A new antipyretic for pediatric usage, 4-(acetamido) phenyl-2-acetoxybenzoate. Thérapie 23, 541 (1968)
Vest, M., Olafsson, A., Girard, J.: Die antipyretische Wirkung von Benorylate, 4-(Acetamido) phenyl-2-acetoxybenzoat, im Vergleich mit Aspirin und Alcaxyl bei Kindern. Ther. Umsch. 28, 625 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Similä, S., Keinänen, S. & Kouvalainen, K. Oral antipyretic therapy. Eur J Pediatr 121, 15–20 (1975). https://doi.org/10.1007/BF00464391
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00464391